Intranasal administration of basic flbroblast growth factor for a rat model of cerebral infarction: an experimental study
Zhao-lu WANG,Qin YIN,Song-ming CHENG,Ge-lin XU,Min-min MA,Ji-ping YANG,Xin-feng LIU
DOI: https://doi.org/10.3969/j.issn.1672-5921.2008.10.005
2008-01-01
Abstract:Objective: To investigate the effect of intranasal administration of basic fibroblast growth factor (bFGF) on regeneration of endogenous neural stem cells in rats with cerebral infarction. Methods: Thirty-six adult male rats were randomly assigned to sham-operation, control and bFGF groups (n=12 in each group). A focal cerebral ischemia/reperfusion model was induced by middle cerebral artery intraluminal suture occlusion (MCAO) method in the control and bFGF groups. Normal saline or bFGF (30 μg per day) was administered intranasally to the control or bFGF group rats from 1 to 6 days after the procedure. After cerebral infarction was established, the degree of neurological functional recovery of rats was assessed by mNSS scores 1, 7, 14, 21 and 28 days before and after the procedures. The volume of cerebral infarction was detected by hematoxylin staining method in rats with cerebral infarction 7 and 28 days after the procedure; the numbers of positive cells in the ipsilateral subventricular zone (SVZ) and bromodeoxyuridine (BrdU) in striatum were assessed by immunohistochemical method; A confocal laser-scanning microscope was used to observe the double-labeled cells of BrdU and doublecortin (DCX) at day 7. Results: As compared with the control group, the rats in bFGF group had significant recovery of neurological function from the 7th days after the procedures (1, 7, 14, 21 and 28 days after the procedures, the scores in the control group were 8.7 ± 1.0, 7.2 ± 0.8, 6.7 ± 1.0, 6.2 ± 0.8 and 5.8 ± 1.2, respectively; the scores in the bFGF group were 8.8 ± 0.8, 6.2 ± 0.8, 5.3 ± 0.8, 5.0 ± 0.6 and 4.3 ± 0.8, respectively; the P values between the two groups at each time point were 0.756, 0.044, 0.033, 0.016 and 0.028, respectively) , which showed its positive intervention effects markedly. However, there were no significant differences between the control and bFGF groups in the volume of cerebral infarction. The immunohistochemistry of BrdU showed that the numbers of bFGF positive cells in SVZ and striatum at 7 and 28 days after the procedures in the bFGF group were significantly higher than those in the control group. The most BrdU positive cells of SVZ at day 7 co-labeled the immature neuronal marker - DCX. Conclusions: Intranasal administration of bFGF may induce the proliferation and survival of endogenous neural stem cells and promote recovery of neurological function, Intranasal adminisit is a promising strategy for the treatment of cerebral infarction.